Jia Jie Biomedical Co., Ltd.(TW:4109)
NT$10.20+0.00 (+0.99%)
TW:4109
Jia Jie Biomedical Co., Ltd. financials statements
NT$10.20
At close:+0.00 (+0.99%)
Jia Jie Biomedical Co., Ltd. (4109) Financial Statements
Jia Jie Biomedical Co., Ltd. Financial Overview
Jia Jie Biomedical Co., Ltd.'s market cap is currently NT$1.21B. The company's EPS TTM is NT$0.04; its P/E ratio is 255.00; and it has a dividend yield of 1.96%. Jia Jie Biomedical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 485.40M | NT$ 537.07M | NT$ 332.76M | NT$ 317.72M | NT$ 242.48M |
| Gross Profit | NT$ 150.34M | NT$ 173.35M | NT$ 117.64M | NT$ 116.51M | NT$ 83.77M |
| Operating Income | NT$ 710.00K | NT$ 33.22M | NT$ -66.20M | NT$ -5.28M | NT$ 5.05M |
| EBITDA | NT$ 18.24M | NT$ 241.93M | NT$ 161.30M | NT$ 12.12M | NT$ 18.58M |
| Net Income | NT$ 50.26M | NT$ 211.37M | NT$ 144.15M | NT$ -5.47M | NT$ 5.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 481.56M | NT$ 263.05M | NT$ 384.17M | NT$ 253.75M | NT$ 286.31M |
| Total Assets | NT$ 1.89B | NT$ 1.48B | NT$ 1.41B | NT$ 1.00B | NT$ 1.02B |
| Total Debt | NT$ 52.96M | NT$ 8.78M | NT$ 76.75M | NT$ 3.73M | NT$ 5.27M |
| Net Debt | NT$ -243.50M | NT$ -104.16M | NT$ -277.68M | NT$ -121.80M | NT$ -167.00M |
| Total Liabilities | NT$ 174.89M | NT$ 123.08M | NT$ 342.69M | NT$ 80.00M | NT$ 86.47M |
| Stockholders' Equity | NT$ 1.68B | NT$ 1.33B | NT$ 1.05B | NT$ 897.98M | NT$ 907.87M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -64.15M | NT$ 24.72M | NT$ -13.10M | NT$ -26.64M | NT$ 2.85M |
| Operating Cash Flow | NT$ 21.34M | NT$ 44.35M | NT$ -4.49M | NT$ -8.78M | NT$ 4.37M |
| Investing Cash Flow | NT$ -186.12M | NT$ -128.15M | NT$ 2.55M | NT$ -35.02M | NT$ -173.05M |
| Financing Cash Flow | NT$ 348.51M | NT$ -158.77M | NT$ 234.57M | NT$ -3.73M | NT$ -2.48M |
Currency in TWD
